Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.2B | 10.1B | 8.7B | 8.8B |
Cost of revenue | 5.5B | 6.3B | 5.2B | 4.8B |
Gross profit | 3.7B | 3.8B | 3.4B | 4.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.7B | 1.6B | 1.4B | 1.5B |
Operating income | 462.9M | 703.6M | 567.9M | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 93.6M | 128.4M | 97.9M | 105.9M |
Other income expense | — | — | — | — |
Pretax income | 378.3M | 643.0M | 623.9M | 981.4M |
Tax provision | 16.5M | 167.6M | 164.8M | 252.6M |
Net income | 361.8M | 475.4M | 459.1M | 728.8M |
Basic EPS | — | 2.3 | 2.2 | 3.5 |
Diluted EPS | — | 2.3 | 2.2 | 3.5 |
Basic average shares | — | 206.7M | 206.8M | 206.5M |
Diluted average shares | — | 206.7M | 206.8M | 206.5M |
EBITDA | 938.5M | 1.3B | 1.2B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |